Magnesium sulfate for preterm neuroprotection

JAMA. 2004 Feb 25;291(8):940-1; author reply 941. doi: 10.1001/jama.291.8.940-c.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cerebral Palsy / prevention & control*
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Infant Mortality
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases / prevention & control*
  • Magnesium Sulfate / administration & dosage*
  • Magnesium Sulfate / adverse effects
  • Neuroprotective Agents / administration & dosage*
  • Neuroprotective Agents / adverse effects
  • Obstetric Labor, Premature
  • Pregnancy
  • Tocolytic Agents / administration & dosage*

Substances

  • Neuroprotective Agents
  • Tocolytic Agents
  • Magnesium Sulfate